Q&A with Agendia CEO David Macdonald

Agendia CEO David Macdonald stopped by GenomeWeb's office in New York City and responded to questions from Turna Ray, editor of Pharmacogenomics Reporter, about his company's MammaPrint breast cancer recurrence test and more.

Other Genomeweb Videos

For Even More Videos Click Here

For Even More Videos Click Here